Jaguar Health, Inc. (JAGX)
0.393
-0.01
(-1.55%)
USD |
NASDAQ |
Mar 24, 15:09
Jaguar Health EPS Diluted (Quarterly) : -6.280 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -3.976 |
| Phio Pharmaceuticals Corp. | -0.2041 |
| MetaVia, Inc. | -1.521 |
| Seastar Medical Holding Corp. | -1.316 |
| Jupiter Neurosciences, Inc. | -0.0672 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.648M |
| Revenue (Quarterly) | 3.083M |
| Total Expenses (Quarterly) | 12.58M |
| Enterprise Value | 30.09M |
| Gross Profit Margin (Quarterly) | 64.58% |
| Profit Margin (Quarterly) | -312.9% |
| Earnings Yield | -8.65K% |
| Normalized Earnings Yield | -7451.91 |